We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+5.66%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$80.1B
AUM Growth
+$9.71B
(+14%)
Cap. Flow
+$17.3B
Cap. Flow
% of AUM
21.56%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
1,430
New
62
Increased
858
Reduced
440
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$13B |
| 2 |
NVIDIA
NVDA
|
+$468M |
| 3 |
ASML
ASML
|
+$424M |
| 4 |
Applied Materials
AMAT
|
+$310M |
| 5 |
Qualcomm
QCOM
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinross Gold
KGC
|
+$444M |
| 2 |
Tyler Technologies
TYL
|
+$256M |
| 3 |
C.H. Robinson
CHRW
|
+$251M |
| 4 |
Philip Morris
PM
|
+$245M |
| 5 |
RTX Corp
RTX
|
+$234M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.76% |
| 2 | Materials | 26.89% |
| 3 | Healthcare | 7.04% |
| 4 | Industrials | 6.5% |
| 5 | Financials | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Southwest Gas
SWX
$6.5B
| $52K | ﹤0.01% |
696
+2
| +0.3% | +$145 |
|
|
RCM
1277
DELISTED
R1 RCM Inc. Common Stock
RCM
| $51K | ﹤0.01% |
3,596
-1,544
| -30% | -$21K |
|
1278
Itron
ITRI
$4.42B
| $46K | ﹤0.01% |
445
+1
| +0.2% | +$101 |
|
1279
Vitamin Cottage Natural Grocers
NGVC
$765M
| $46K | ﹤0.01% |
1,726
-642
| -27% | -$16.3K |
|
1280
ZTO Express
ZTO
$18.7B
| $46K | ﹤0.01% |
1,825
+690
| +61% | +$14.3K |
|
|
CVGW
1281
DELISTED
Calavo Growers
CVGW
| $41K | ﹤0.01% |
1,503
-559
| -27% | -$13.7K |
|
1282
Guardant Health
GH
$21.3B
| $40K | ﹤0.01% |
1,958
-897
| -31% | -$25.4K |
|
|
FOLD
1283
DELISTED
Amicus Therapeutics
FOLD
| $39K | ﹤0.01% |
3,457
-1,107
| -24% | -$12.1K |
|
1284
Limoneira
LMNR
$239M
| $39K | ﹤0.01% |
1,454
-663
| -31% | -$15.2K |
|
1285
Beyond Meat
BYND
$316M
| $38K | ﹤0.01% |
6,218
-2,292
| -27% | -$14.5K |
|
1286
Itaú Unibanco
ITUB
$93.6B
| $38K | ﹤0.01% |
6,878
+2,797
| +69% | +$15.8K |
|
1287
Grupo Aeroportuario del Pacifico
PAC
$13B
| $38K | ﹤0.01% |
220
+89
| +68% | +$14.7K |
|
1288
Dentsply Sirona
XRAY
$2.83B
| $37K | ﹤0.01% |
+1,556
| New | +$39.7K |
|
1289
Laureate Education
LAUR
$5.18B
| $36K | ﹤0.01% |
2,259
+763
| +51% | +$11.7K |
|
1290
Herbalife
HLF
$1.32B
| $35K | ﹤0.01% |
5,002
-3,682
| -42% | -$33.9K |
|
1291
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $35K | ﹤0.01% |
+366
| New | +$35.4K |
|
1292
Arrowhead Research
ARWR
$12.1B
| $34K | ﹤0.01% |
1,728
-1,250
| -42% | -$30.5K |
|
1293
Federated Hermes
FHI
$4.85B
| $34K | ﹤0.01% |
899
+83
| +10% | +$2.84K |
|
1294
Coupang
CPNG
$29.5B
| $32K | ﹤0.01% |
1,251
+484
| +63% | +$10.8K |
|
1295
Intellia Therapeutics
NTLA
$1.5B
| $32K | ﹤0.01% |
1,594
-594
| -27% | -$13.7K |
|
|
PINC
1296
DELISTED
Premier
PINC
| $32K | ﹤0.01% |
1,595
-1,003
| -39% | -$19.9K |
|
1297
Thor Industries
THO
$4.03B
| $32K | ﹤0.01% |
+309
| New | +$31.4K |
|
1298
VanEck High Yield Muni ETF
HYD
$4.42B
| $31K | ﹤0.01% |
599
+4
| +0.7% | +$210 |
|
1299
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.04B
| $30K | ﹤0.01% |
1,024
-9,290
| -90% | -$269K |
|
1300
Evolent Health
EVH
$353M
| $30K | ﹤0.01% |
1,356
-677
| -33% | -$17.4K |
|
Similar funds
VanEck Associates's Q3 2024 Portfolio in Review
As of Q3 2024, VanEck Associates held 1,430 positions worth $80.1B, up 14% from $70.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
VanEck Associates deployed $17.3B of net new capital in Q3 2024, opening 62 new positions and adding to 858 existing holdings. Its largest new stake was GE HealthCare: 2,335,235 shares worth $209M.
By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 42% a quarter earlier, followed by Materials and Healthcare.
On the sell side, the largest reduction was Kinross Gold, an estimated $444M trimmed.
- VanEck Associates's largest Q3 2024 buy was GE HealthCare: 2,335,235 shares worth $209M.
- VanEck Associates added most to Lam Research in Q3 2024, an estimated $13B increase.
- VanEck Associates's biggest Q3 2024 reduction was Kinross Gold, cutting an estimated $444M.
- VanEck Associates fully exited RBC Bearings Incorporated 5.00% Series A Mandatory Convertible Preferred Stock in Q3 2024, selling an estimated $22.4M.
- VanEck Associates's ten largest holdings make up 29% of its $80.1B portfolio in Q3 2024.
- VanEck Associates opened 62 new positions and closed 53 in Q3 2024.
- VanEck Associates's portfolio value rose 14% quarter-over-quarter to $80.1B.
Based on VanEck Associates's 13F filing for Q3 2024, filed 29 Oct 2024.